lomustine has been researched along with Genetic Predisposition in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morabito, F | 1 |
| Hohaus, S | 1 |
| Mammi, C | 1 |
| Marcheselli, L | 1 |
| Gentile, M | 1 |
| Merli, F | 1 |
| Montanini, A | 1 |
| Stelitano, C | 1 |
| La Sala, A | 1 |
| Scalone, R | 1 |
| Voso, MT | 1 |
| Luminari, S | 1 |
| Iannitto, E | 1 |
| Gobbi, P | 1 |
| Federico, M | 1 |
| Walker, C | 2 |
| Haylock, B | 2 |
| Husband, D | 2 |
| Joyce, KA | 2 |
| Fildes, D | 2 |
| Jenkinson, MD | 2 |
| Smith, T | 2 |
| Broome, J | 2 |
| du Plessis, DG | 2 |
| Warnke, PC | 2 |
| Kopitzki, K | 1 |
| Prosser, J | 1 |
| Vinjamuri, S | 1 |
1 trial available for lomustine and Genetic Predisposition
| Article | Year |
|---|---|
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carbopl | 2012 |
2 other studies available for lomustine and Genetic Predisposition
| Article | Year |
|---|---|
Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Case-Control Studies; | 2006 |
Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, | 2006 |